In the follow-up investigation, we profiled a cohort of eight untreated primary PCa patient samples using the previously determined 9-molecule surface fingerprint of docetaxel-resistant cells combined with the epithelial marker EpCAM (Supplementary Table S3). This evidence concerns the gene EPCAM and posterior cortical atrophy.